Stay updated on Pembrolizumab in Pediatric Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Pediatric Solid Tumors Clinical Trial page.

Latest updates to the Pembrolizumab in Pediatric Solid Tumors Clinical Trial page
- Check3 days agoChange DetectedAdded a line '2014 ( U.S. NIH Grant/Contract )' under Other Study ID Numbers. This records NIH funding as part of the study's identifiers.SummaryDifference0.0%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedA new page revision tag Revision: v3.6.5 was added, and the Plain Language Summary along with the older Revision: v3.6.4 were removed.SummaryDifference0.1%

- Check32 days agoChange DetectedAn update changes the page's revision label from v3.6.3 to v3.6.4, signaling a minor platform update with no visible changes to the study details.SummaryDifference0.0%

- Check54 days agoChange DetectedThe recruitment locations count was updated from 17 to 16. The Haarlem, Netherlands listing and the contact name Caroline Doornebos were removed from the Recruiting section.SummaryDifference0.5%

- Check61 days agoChange DetectedRevision label on the page was updated from v3.6.0 to v3.6.2, indicating an update to the page’s underlying software version.SummaryDifference0.0%

- Check75 days agoChange DetectedAdded navigation/help sections to the Study Details page (Check who can join, Find Contact Information, How to Read a Study Record, Common Questions, How to Join a Study). Standardized the Intervention/Treatment label formatting (Intervention/Treatment instead of Intervention / Treatment) and updated the page revision from v3.5.5 to v3.6.0.SummaryDifference0.4%

Stay in the know with updates to Pembrolizumab in Pediatric Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Pediatric Solid Tumors Clinical Trial page.